ARTAN Bio has raised $200,000 in a seed funding round to advance its longevity biotechnologies, focusing on nonsense mutations. This funding will support preclinical development and innovation protection.
Amount Raised
$200,000
Round Type
Seed
Saint PetersburgBiotechnologyHealth CareDescription
ARTAN Bio, a longevity biotechnology company in St. Petersburg, has completed a $200,000 seed raise to fund the preclinical advancement of its engineered suppressor platform targeting nonsense mutations. The raise will support validation in animal models and intellectual property filings. This marks a significant advance in addressing genetic errors linked to aging-related diseases
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as ARTAN Bio that raised within 45 days of this round, from Fundz verified event records.
- Sielo Robotics raised $1M (Seed) on July 19, 2026.
- ME Therapeutics Holdings raised $457K (Post-IPO Equity) on July 17, 2026.
- Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
- Bunkerhill Health raised $55M on July 16, 2026.
- Neuble AI raised $269K (Seed) on July 16, 2026.
- Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
Who to call at ARTAN Bio, and when
A new round usually means ARTAN Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ARTAN Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARTAN Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARTAN Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARTAN Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ARTAN Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.